MedTech Business - November 13, 2024
Capitainer expands operations with enhanced US presence
Capitainer has announced the establishment of Capitainer Inc. in the United States. This expansion will enhance customer service and streamline order processing for the company’s growing US market, further strengthening Capitainer’s goal to become the gold standard and global leader in self-sampling, the company states.
Financing - November 12, 2024
SciBase decides on a directed issue and a rights issue
The Board of Directors of SciBase has decided to carry out a capital raise totaling approximately SEK 81.8 million.
Financing - October 2, 2024
Spago Nanomedical enters a new phase
The Board of Directors of Spago Nanomedical has decided that the company's resources will be focused on the development of Tumorad with the company's primary priority being the execution of the ongoing clinical study Tumorad-01 with the candidate drug 177Lu-SN201.
Financing - October 2, 2024
Senzime carries out a directed share issue of SEK 86 million
The board of directors of Senzime has resolved on a directed share issue of a maximum of 13 873 000 shares at the subscription price of SEK 6.20 per share.
MedTech Business - September 20, 2024
Medical vest aims to enable cancer treatment for children
For seriously ill children and adolescents, intravenous drip stands can significantly hinder mobility.
Acquisition - August 23, 2024
Getinge to acquire Paragonix Technologies
Getinge has announced an agreement to acquire 100% of Paragonix Technologies for an aggregated purchase price, including upfront and earn out payments, estimated to approximately USD 477 million. The acquisition aligns with Getinge’s broader strategy to expand its portfolio into high growth markets that complement and enhance its acute heart and lung support offering already […]
